(Q34570040)

3 August 2017

1 reference

title

Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirus (English)

1 reference

3 August 2017

0 references

B Abdulkarim

1

1 reference

3 August 2017

J Bourhis

series ordinal

2

1 reference

3 August 2017

publication date

1 October 2001

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

622-630

1 reference

3 August 2017

cites work

Viruses in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Transforming proteins of the papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Inhibition of Bak-induced apoptosis by HPV-18 E6.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Papillomavirus-like particle vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Treatment of latent rabbit and human papillomavirus infections with 9-(2-phosphonylmethoxy)ethylguanine (PMEG)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Activation of p53 in cervical carcinoma cells by small molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900520-4

7 January 2021

10.1016/S1470-2045(01)00520-4

Identifiers

DOI

1 reference

3 August 2017

1 reference